Polymeric delivery systems as a potential vaccine against Visceral Leishmaniasis : formulation development and immunogenicity.

• Autor(a) principal: Silva, João Guilherme Lino da
• Data de Publicação: 2023
• Outros Autores: Gonçalves, Ana Alice Maia, Oliveira, Liliam Teixeira, Garcia, Giani Martins, Batista, Maurício Azevedo, Mendonça, Ludmila Zanandreis de, Viana, Kelvinson Fernandes, Sant’Ana, Rita de Cássia Oliveira, Melo Júnior, Otoni Alves de Oliveira, Lemos, Denise Silveira, Dutra, Walderez Ornelas, Martins-Filho, Olindo Assis, Galdino, Alexsandro Sobreira, Moura, Sandra Aparecida Lima de, Mosqueira, Vanessa Carla Furtado, Giunchetti, Rodolfo Cordeiro, Garcia 3 , , Giani Martins
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFOP
• Texto Completo: https://www.repositorio.ufop.br/handle/123456789/18812; https://doi.org/10.3390/vaccines11081309
• topic: Visceral leishmaniasis; Submicrometric particles; Vaccine; Polymeric nanoparticles

Recent studies suggest that the association of antigens in microparticles increases the anti-Leishmania vaccine immunogenicity. This study aims to investigate the in situ effect of the adjuvant performance consisting of chitosan-coated poly(D,L-lactic) acid submicrometric particles (SMP) and analyze the inflammatory profile and toxicity. Two formulations were selected, SMP1, containing poly(D,L-lactide) (PLA) 1% wt/v and chitosan 1% wt/v; and SMP2, containing PLA 5% wt/v and chitosan 5% wt/v. After a single dose of the unloaded SMP1 or SMP2 in mice, the SMPs promoted cell recruitment without tissue damage. In addition, besides the myeloperoxidase (MPO) activity having demonstrated similar results among the analyzed groups, a progressive reduction in the levels of N-acetyl-β-D-glucosaminidase (NAG) until 72 h was observed for SMPs. While IL-6 levels were similar among all the analyzed groups along the kinetics, only the SMPs groups had detectable levels of TNF-α. Additionally, the Leishmania braziliensis antigen was encapsulated in SMPs (SMP1Ag and SMP2Ag), and mice were vaccinated with three doses. The immunogenicity analysis by flow cytometry demonstrated a reduction in NK (CD3−CD49+) cells in all the SMPs groups, in addition to impairment in the T cells subsets (CD3+CD4+) and CD3+CD8+) and B cells (CD19+) of the SMP2 group. The resulting data demonstrate that the chitosan-coated SMP formulations stimulate the early events of an innate immune response, suggesting their ability to increase the immunogenicity of co-administered Leishmania antigens.